Technology | June 27, 2006

Hitachi's SceptreC Cardiac PET system designed specifically for cardiac PET, and may serve as an as an alternative solution to SPECT or PET/CT for myocardial perfusion and viability studies. The SceptreC utilizes both Rubidium-82 for myocardial perfusion and 18-FDG for myocardial viability procedures. "Whole-body PET/CT offers significant throughput advantages for oncology,” said Raymond Wtulich, PET and PET/CT product manager, Hitachi Medical Systems America Inc. β€œHowever, in cardiac imaging only one bed position is required for a stress or rest acquisition, making dedicated PET a comparable throughput solution at a dramatically lower cost for both equipment and service.”
With reportedly just 40-second acquisition times for both stress and rest myocardial perfusion, SceptreC is also optimized with 3-D Pico electronics to provide high-count rate capability and equipped with cardiac quantification software to deliver an alternative to SPECT or PET/CT.

Related Content

News | FDA

January 23, 2024 β€” Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...

Time January 23, 2024
News | Artificial Intelligence

January 23, 2024 β€” Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...

Time January 22, 2024
News | Radiology Business

December 27, 2023 β€” The American Roentgen Ray Society (ARRS) announced David M. Naeger, MD, as the 2024 ARRS ...

Time December 27, 2023
News | Radiopharmaceuticals and Tracers

December 6, 2023 β€” Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...

Time December 06, 2023
News | Radiology Imaging

November 30, 2023 β€” Through its leading imaging solutions and commitment to innovation, GE HealthCare remains at the ...

Time November 30, 2023
News | Quality Assurance (QA)

November 25, 2023 β€” Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry ...

Time November 25, 2023
News | PET-CT

November 22, 2023 β€” Siemens Healthineers has announced the U.S. Food and Drug Administration (FDA) clearance of the ...

Time November 22, 2023
News | Breast Imaging

October 11, 2023 β€” A new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth ...

Time October 11, 2023
News | X-Ray

September 21, 2023 β€” Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT ...

Time September 21, 2023
News | Prostate Cancer

August 15, 2023 β€” In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid ...

Time August 15, 2023
Subscribe Now